Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
May 14, 2015Journal of Antimicrobial Chemotherapy

Genome sequencing reveals novel deletions associated with secondary resistance to pyrazinamide in MDRMycobacterium tuberculosis

View Full Paper
Ask AI
Bookmark
Share

Authors

EMElena MartínezNew South Wales Department of HealthNHNadine HolmesUniversity of NottinghamPJPeter JelfsNew South Wales Department of Health

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Martínez et al. (2015) studied this question.

synapsesocial.com/papers/6a6f91d05d37378ac1dca057https://doi.org/10.1093/jac/dkv128
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Role of rpsA Gene Sequencing in Diagnosis of Pyrazinamide Resistance2012 · 40 citations
  2. 2Characterization of pncA mutations in pyrazinamide-resistant Mycobacterium tuberculosis1997 · 336 citations
  3. 3Systems approach to tuberculosis vaccine development2013 · 30 citations
  4. 4Mycobacterium tuberculosis thymidylate synthase gene thyX is essential and potentially bifunctional, while thyA deletion confers resistance to p-aminosalicylic acid2011 · 94 citations
  5. 5Automated High-Throughput Genotyping for Study of Global Epidemiology of Mycobacterium tuberculosis Based on Mycobacterial Interspersed Repetitive Units2001 · 597 citations